Cargando…
The tumor suppressor Hic1 maintains chromosomal stability independent of Tp53
Hypermethylated-in-Cancer 1 (Hic1) is a tumor suppressor gene frequently inactivated by epigenetic silencing and loss-of-heterozygosity in a broad range of cancers. Loss of HIC1, a sequence-specific zinc finger transcriptional repressor, results in deregulation of genes that promote a malignant phen...
Autores principales: | Szczepny, Anette, Carey, Kirstyn, McKenzie, Lisa, Jayasekara, W. Samantha N., Rossello, Fernando, Gonzalez-Rajal, Alvaro, McCaw, Andrew S., Popovski, Dean, Wang, Die, Sadler, Anthony J., Mahar, Annabelle, Russell, Prudence A., Wright, Gavin, McCloy, Rachael A., Garama, Daniel J., Gough, Daniel J., Baylin, Stephen B., Burgess, Andrew, Cain, Jason E., Watkins, D. Neil |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5886987/ https://www.ncbi.nlm.nih.gov/pubmed/29367758 http://dx.doi.org/10.1038/s41388-017-0022-1 |
Ejemplares similares
-
Ligand-dependent hedgehog signaling maintains an undifferentiated, malignant osteosarcoma phenotype
por: Vaghjiani, Vijesh G., et al.
Publicado: (2023) -
Deep multi-region whole-genome sequencing reveals heterogeneity and gene-by-environment interactions in treatment-naive, metastatic lung cancer
por: Leong, Tracy L., et al.
Publicado: (2018) -
The Role of Canonical and Non-Canonical Hedgehog Signaling in Tumor Progression in a Mouse Model of Small Cell Lung Cancer
por: Szczepny, Anette, et al.
Publicado: (2017) -
In the By-ways of Medicine
por: McCloy, J. M.
Publicado: (1939) -
Sustained Low-Dose Treatment with the Histone Deacetylase Inhibitor LBH589 Induces Terminal Differentiation of Osteosarcoma Cells
por: Cain, Jason E., et al.
Publicado: (2013)